|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Ra Pharmaceuticals, Inc. (RARX) |
|
|
$46.96 0.00 (0.00%) as of 4:30 Thu 3/19
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,150,000 |
Market
Cap: |
2.21(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$46.96 - $46.96 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Novartis Ag |
10% Owner |
|
2017-05-26 |
4 |
S |
$25.14 |
$133,267 |
D/D |
(5,300) |
2,386,599 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-05-25 |
4 |
S |
$25.00 |
$1,325 |
D/D |
(53) |
2,391,899 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-05-24 |
4 |
S |
$25.01 |
$436,364 |
D/D |
(17,451) |
2,391,952 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-05-18 |
4 |
S |
$25.50 |
$229,964 |
D/D |
(9,019) |
2,409,403 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-05-17 |
4 |
S |
$25.51 |
$574,901 |
D/D |
(22,534) |
2,418,422 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-05-16 |
4 |
S |
$26.33 |
$528,725 |
D/D |
(20,081) |
2,440,956 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-03-01 |
4 |
S |
$20.91 |
$162,658 |
D/D |
(7,778) |
2,461,037 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-02-28 |
4 |
S |
$20.86 |
$163,670 |
D/D |
(7,847) |
2,468,815 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-02-27 |
4 |
S |
$20.96 |
$1,212,306 |
D/D |
(57,844) |
2,476,662 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-02-24 |
4 |
S |
$20.93 |
$113,000 |
D/D |
(5,398) |
2,534,506 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-02-23 |
4 |
S |
$21.04 |
$105,160 |
D/D |
(4,999) |
2,539,904 |
|
- |
|
Novartis Ag |
10% Owner |
|
2017-02-22 |
4 |
S |
$21.86 |
$16,370 |
D/D |
(749) |
2,544,903 |
|
- |
|
Novo A/s |
10% Owner |
|
2016-10-31 |
4 |
B |
$13.00 |
$3,200,002 |
D/D |
246,154 |
2,031,562 |
2.45 |
- |
|
Novo A/s |
10% Owner |
|
2016-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,785,408 |
1,785,408 |
|
- |
|
Kolluri Krishna Kittu |
10% Owner |
|
2016-10-31 |
4 |
B |
$13.00 |
$4,400,006 |
I/I |
338,462 |
3,490,073 |
1.5 |
- |
|
Kolluri Krishna Kittu |
10% Owner |
|
2016-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
3,071,388 |
3,151,611 |
|
- |
|
Kolluri Krishna Kittu |
10% Owner |
|
2016-10-31 |
4 |
S |
$13.00 |
$5,655 |
I/I |
(435) |
80,223 |
|
- |
|
Kolluri Krishna Kittu |
10% Owner |
|
2016-10-31 |
4 |
OE |
$0.07 |
$5,646 |
I/I |
80,658 |
80,658 |
|
- |
|
Novartis Ag |
10% Owner |
|
2016-10-31 |
4 |
B |
$13.00 |
$1,099,995 |
D/D |
84,615 |
2,545,652 |
2.45 |
- |
|
Novartis Ag |
10% Owner |
|
2016-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,398,462 |
2,461,037 |
|
- |
|
Novartis Ag |
10% Owner |
|
2016-10-31 |
4 |
S |
$13.00 |
$4,407 |
D/D |
(339) |
62,575 |
|
- |
|
Novartis Ag |
10% Owner |
|
2016-10-31 |
4 |
OE |
$0.07 |
$4,404 |
D/D |
62,914 |
62,914 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2016-10-31 |
4 |
B |
$13.00 |
$4,400,006 |
I/I |
338,462 |
3,490,073 |
1.5 |
- |
|
Sandell Scott D |
10% Owner |
|
2016-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
3,071,388 |
3,151,611 |
|
- |
|
Sandell Scott D |
10% Owner |
|
2016-10-31 |
4 |
S |
$13.00 |
$5,655 |
I/I |
(435) |
80,223 |
|
- |
|
148 Records found
|
|
Page 4 of 6 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|